Friday, 16 October 2026European Markets

BARBARA BUI Stock Bullish By 21% In The Last 10 Sessions

Loading stream...

french clothing brand, barbara bui (bui.pa), has recently experienced some significant financial fluctuations. over a span of 10 sessions, the company saw a surprising 22% surge, its shares rising from eur7.3 to eur8.90. this occurred in contrast to the overall performance of france's benchmark cac 40 index, which fell 0.1% to reach eur7,260.25. even more noteworthy is that this rise came amidst five consecutive sessions of losses and an overall decline in france of 0.1%.

bui.pa share performance

despite their recent surge, it's important to note that bui.pa shares still remain more than 15% below their 52-week high of eur10.50. this rapid volatility is a potent reminder for shareholders of the inherent risks in stock trading, emphasizing the need for maintaining a long-term perspective and diversifying portfolios for maximum protection.

financial performance of bui.pa

the financial health of bui.pa can be assessed primarily through its earnings per share, which have amounted to eur1.61 over the last twelve months. additionally, its application of the price-to-earnings (p/e) ratio, a method often employed by investors to gauge a stock's value, currently sits at 5.53. this means investors are paying eur5.53 for each euro of bui.pa's annual earnings.

return on equity

with a return on equity (roe) of 61.8% over the last year, bui.pa demonstrates notable profitability relative to shareholder equity. the high roe indicates a capacity to generate substantial profits with limited capital - a trait that typically attracts investors.

stochastic oscillator analysis

despite these strong financials, potential investors should proceed with careful analysis before purchasing shares of bui.pa. according to the stochastic oscillator, a frequently-used momentum indicator, the stock is currently in an overbought state. this implies that a price correction may be looming on the horizon.

in conclusion, investors with a comprehensive understanding of both micro and macroeconomic trends, such as company profits and overall market movement, will be best positioned to navigate this uncertain landscape.

more news about barbara bui (bui.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com